Literature DB >> 10514014

Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice.

H Tsutsui1, N Kayagaki, K Kuida, H Nakano, N Hayashi, K Takeda, K Matsui, S Kashiwamura, T Hada, S Akira, H Yagita, H Okamura, K Nakanishi.   

Abstract

IL-18, produced as a biologically inactive precursor, is processed by caspase-1 in LPS-activated macrophages. Here, we investigated caspase-1-independent processing of IL-18 in Fas ligand (FasL)-stimulated macrophages and its involvement in liver injury. Administration of Propionibacterium acnes (P. acnes) upregulated functional Fas expression on macrophages in an IFNgamma-dependent manner, and these macrophages became competent to secrete mature IL-18 upon stimulation with FasL. This was also the case for caspase-1-deficient mice. Administration of recombinant soluble FasL (rFasL) after P. acnes priming induced comparable elevation of serum IL-18 in parallel with elevated serum liver enzyme levels. However, liver injury was not induced in IL-18-deficient mice after rFasL administration. These results indicate a caspase-1-independent pathway of IL-18 secretion from FasL-stimulated macrophages and its critical involvement in FasL-induced liver injury.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10514014     DOI: 10.1016/s1074-7613(00)80111-9

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  71 in total

1.  Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease.

Authors:  Othmar Ludwiczek; Arthur Kaser; Daniela Novick; Charles A Dinarello; Menachem Rubinstein; Wolfgang Vogel; Herbert Tilg
Journal:  J Clin Immunol       Date:  2002-11       Impact factor: 8.317

Review 2.  Historical insights into cytokines.

Authors:  Charles A Dinarello
Journal:  Eur J Immunol       Date:  2007-11       Impact factor: 5.532

3.  Protection against Fas-mediated and tumor necrosis factor receptor 1-mediated liver injury by blockade of FADD without loss of nuclear factor-kappaB activation.

Authors:  K Seino; Y Setoguchi; T Ogino; N Kayagaki; H Akiba; H Nakano; H Taniguchi; Y Takada; K Yuzawa; T Todoroki; Y Fukuchi; H Yagita; K Okumura; K Fukao
Journal:  Ann Surg       Date:  2001-11       Impact factor: 12.969

4.  Interferon-alpha induces interleukin-18 binding protein in chronic hepatitis C patients.

Authors:  A Kaser; D Novick; M Rubinstein; B Siegmund; B Enrich; R O Koch; W Vogel; S H Kim; C A Dinarello; H Tilg
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

5.  Interleukin-18 promotes joint inflammation and induces interleukin-1-driven cartilage destruction.

Authors:  Leo A B Joosten; Ruben L Smeets; Marije I Koenders; Liduine A M van den Bersselaar; Monique M A Helsen; Birgitte Oppers-Walgreen; Erik Lubberts; Yoichiro Iwakura; Fons A J van de Loo; Wim B van den Berg
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

6.  Bystander suppression of allergic airway inflammation by lung resident memory CD8+ T cells.

Authors:  Benjamin J Marsland; Nicola L Harris; Mali Camberis; Manfred Kopf; Sarah M Hook; Graham Le Gros
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205

7.  TLRs, NF-κB, JNK, and Liver Regeneration.

Authors:  Yuji Iimuro; Jiro Fujimoto
Journal:  Gastroenterol Res Pract       Date:  2010-09-26       Impact factor: 2.260

8.  Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance.

Authors:  Ping An; Chloe L Thio; Gregory D Kirk; Sharyne Donfield; James J Goedert; Cheryl A Winkler
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

Review 9.  The intersection of cell death and inflammasome activation.

Authors:  James E Vince; John Silke
Journal:  Cell Mol Life Sci       Date:  2016-04-11       Impact factor: 9.261

10.  Host-derived interleukin-18 differentially impacts regulatory and conventional T cell expansion during acute graft-versus-host disease.

Authors:  Robert Zeiser; Elizabeth A Zambricki; Dennis Leveson-Gower; Neeraja Kambham; Andreas Beilhack; Robert S Negrin
Journal:  Biol Blood Marrow Transplant       Date:  2007-10-29       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.